| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
9,133 |
8,719 |
$358K |
| J0178 |
Injection, aflibercept, 1 mg |
507 |
489 |
$328K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
395 |
373 |
$320K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
6,776 |
6,324 |
$271K |
| 92250 |
|
10,469 |
9,771 |
$246K |
| J9035 |
Injection, bevacizumab, 10 mg |
337 |
293 |
$18K |
| Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg |
16 |
16 |
$10K |
| 92134 |
|
83 |
75 |
$2K |
| 92235 |
|
39 |
37 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17 |
16 |
$1K |
| 92225 |
|
23 |
12 |
$236.88 |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
15 |
15 |
$111.58 |